The eSAH score: a simple practical predictive model for SAH mortality and outcomes
- PMID: 39730519
- PMCID: PMC11681261
- DOI: 10.1038/s41598-024-80524-w
The eSAH score: a simple practical predictive model for SAH mortality and outcomes
Abstract
We developed a simple quantifiable scoring system that predicts aneurysmal subarachnoid hemorrhage (aSAH) mortality, delayed cerebral ischemia (DCI), and modified Rankin scale (mRS) outcomes using readily available SAH admission data with SAH volume (SAHV) measured on computed tomography (CT). We retrospectively analyzed a cohort of 277 patients with aSAH admitted at our Comprehensive Stroke Center at Mayo Clinic in Jacksonville, Florida, between January 5, 2012, and February 24, 2022. We developed a mathematical radiographic model SAHV that measures basal cisternal SAH blood volume using a derivation of the ABC/2 ellipsoid formula (A = width/thickness, B = length, C = vertical extension) on noncontrast CT, which we previously demonstrated is comparable to pixel-based manual segmentation on noncontrast CT. Data were analyzed using t test, χ2 test, receiver operator characteristics curve, and area under the curve (AUC) analysis. Multivariate logistic regression analysis with stepwise elimination of variables not contributing to the model (0.05 significance level for entry into the model) was used to develop an enhanced SAH (eSAH) scoring system. Using multivariate logistic regression, we found that age, Glasgow Coma Scale score, and SAHV were significantly associated with mRS outcomes at discharge, in-hospital DCI, and in-hospital mortality. Using these factors, we developed a weighted eSAH score, ranging from 0 to 5, that was strongly predictive of mRS outcomes (AUC = 0.89), DCI (AUC = 0.75), and in-hospital mortality (AUC = 0.88). Our proposed eSAH score, a simple quantitative model based on SAHV, Glasgow Coma Scale score, and age, appears to predict mortality and outcomes in patients with aSAH. A larger cohort validation study is planned.
Keywords: Computed axial tomography; Delayed cerebral ischemia; Mortality; Multivariate analysis; Outcome; Subarachnoid hemorrhage; eSAH score.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: This study was approved by the Mayo Clinic Institutional Review Board (IRB) as a minimal risk protocol given deidentified data. This means that Mayo Clinic IRB allows this research under certain stipulations where the data is deidentified and poses minimal risk to subjects and cannot be practically carried out otherwise. Informed consent: Consent was waived for this retrospective study by Mayo Clinic Institutional Review Board. This study was performed in accordance with relevant guidelines and regulations.
Figures



References
-
- Cross, D. T. et al. Mortality rates after subarachnoid hemorrhage: Variations according to hospital case volume in 18 states. J. Neurosurg.99, 810–817 (2003). - PubMed
-
- Macdonald, R. L. & Schweizer, T. A. Spontaneous subarachnoid haemorrhage. Lancet389, 655–666 (2017). - PubMed
-
- Mahlamäki, K., Rautalin, I. & Korja, M. Case Fatality Rates of Subarachnoid Hemorrhage are decreasing with substantial between-country variation: A systematic review of Population-based studies between 1980 and 2020. Neuroepidemiology2022, 1–11 . - PubMed
-
- Eagles, M. E., Tso, M. K. & Macdonald, R. L. Cognitive impairment, functional outcome, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. World Neurosurg.124, e558–e562 (2019). - PubMed
-
- Ignacio, K. H. D. et al. Predictive value of hematologic inflammatory markers in delayed cerebral ischemia after Aneurysmal Subarachnoid Hemorrhage. World Neurosurg.160, e296–e306 (2022). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources